scispace - formally typeset
Journal ArticleDOI

Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in vitro to in vivo data

Reads0
Chats0
TLDR
There are intracellular factors which influence clinical radioresponsiveness whose relative importance varies from one histological cell type to another, and there are other factors which specifically reduce radiosensitivity in vivo.
Abstract
The radiosensitivities of human tumor cell lines, grouped into 6 histological categories, have been studied using data from the published literature. The parameters alpha, beta, n, D0, D, and the surviving fraction to 2 Gy (S2) and 8 Gy (S8) were calculated. Only the two parameters mainly derived from the initial part of the survival curve, alpha and D, together with S2, provided data which were correlated with the clinical radioresponsiveness of each histological group. Thus, there are intracellular factors which influence clinical radioresponsiveness whose relative importance varies from one histological cell type to another. The value of D gave the most precise characterization of the average group radiosensitivity. It was possible to compare the in vivo radiosensitivities of non-severely hypoxic cells with those of tumor cells irradiated in vitro for 7 tumor lines grown as xenografts in mice. The average radiosensitivity was 1.9 times less in vivo than in vitro. This difference indicates that, in addition to the intrinsic factors of radioresistance demonstrated in vitro, and independently of severe hypoxia, there are other factors which specifically reduce radiosensitivity in vivo.

read more

Citations
More filters
Journal ArticleDOI

Exploring the role of cancer stem cells in radioresistance.

TL;DR: This work states that new technologies allow isolation of cells expressing specific surface markers that are differentially expressed in tumour cell subpopulations that are enriched for cancer stem cells, and Combining these techniques with functional radiobiological assays holds the potential to elucidate the role of cancer stem Cells in radioresistance in individual tumours.
Journal ArticleDOI

Radioimmunotherapy of human tumours

TL;DR: The cumulative advances in cancer biology, antibody engineering and radiochemistry in the past decade have markedly enhanced the ability of RIT to produce durable remissions of multiple cancer types.
Journal Article

p53 Effects Both the Duration of G2/M Arrest and the Fate of Temozolomide-treated Human Glioblastoma Cells

TL;DR: The results suggest that glioma cells respond to TMZ by undergoing G2-M arrest, and the integrity of the G1-M cell cycle checkpoint may be important in the cytotoxicity of TMZ in gliomas.
Journal ArticleDOI

Extending the linear–quadratic model for large fraction doses pertinent to stereotactic radiotherapy

TL;DR: It is indicated that the standard LQ model can lead to erroneous results when used to calculate iso-effects with large fraction doses, such as those used for ESR.
Journal ArticleDOI

Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments.

TL;DR: The high heterogeneity of CSC subclones along with changes of the functional behavior of individual tumors under treatment underlines the importance of the selection of the optimal timepoint(s) of biomarker evaluation, but also provides a potential therapeutic target for combined treatment approaches with irradiation.
References
More filters
Journal ArticleDOI

Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy

TL;DR: Using the linear quadratic (L-Q) model, a correlation is found between the 95% tumor control dose and the mean surviving fraction at 2 Gy for a given cell type, which suggests that the moderate radiocurability of certain tumors can be partially explained by the intrinsic radiosensitivity of relevant tumor cells.
Journal ArticleDOI

Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves.

TL;DR: It was found that cells from tumors with low radioresponsiveness (melanomas and glioblastomas) are the less radiosensitive, and the range of survival at a dose of 2 Gy is broad enough to account, in large measure, for observed differences in clinical tumor radiore sponsorship.
Journal ArticleDOI

The radioresponsiveness of human tumours and the initial slope ofthe cell survival curve

TL;DR: The surviving fraction at 2 Gy is shown to give good discrimination between resistant and sensitive tumour types and the relationship between the initial slope of the cell survival curve and clinical radioresponsiveness is demonstrated.
Related Papers (5)